Monday Aug 18
Medical News Today
Sanofi pasteur announces publication of positive data for Fluzone high-dose vaccine
Sanofi Pasteur, the vaccines division of Sanofi, has announced that The New England Journal of Medicine published positive results from a large-scale, multi-center efficacy trial, which found that Fluzone High-Dose was more efficacious in preventing influenza in adults 65 years of age and older compared to standard-dose Fluzone vaccine.
The Straits Times
New dengue vaccine not effective enough for Singapore: Vivian Balakrishnan
A file photo taken on Sept 2, 2010 shows the Aedes aegypti mosquito that can spread dengue fever, at an entomology laboratory in Fort-de-France, in Martinique.
Dengue vaccine is just a year away, researchers say
Sanofi Pasteur, the pharmaceutical company that sponsored the development of the vaccine, has announced that it will be commercially available by July 2015.
The Indian Express
First glimmer: After Asian success, dengue vaccine trials come to India
With no treatment in line for dengue, unlike malaria, control and prevention of this disease has posed a major challenge.
KaloBios dips as Sanofi Pasteur returns infection-fighting drug
Sanofi Pasteur returned the rights to an experimental infection-fighting drug to KaloBios Pharmaceuticals Inc., sending the South San Francisco company's stock to a new 52-week low.